About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of LY3819469 in Healthy Participants

NCT04914546·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Eli Lilly and Company

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Female participants must not be able to get pregnant and male participants must agree to adhere to contraception restrictions
Have a body mass index (BMI) of 18.5 to 40.0 kilograms per square meter (kg/m²)
For Part B, participants should be of first-generation Japanese origin

You may not be if

Are currently participating in or completed a clinical trial within the last 30 days
Are heavy alcohol drinkers or heavy cigarette smokers
Have donated blood of more than 500 milliliters (mL) in the last 3 months

The record

StatusCompleted

PhasePhase 1

Taking part66

StartedJun 2021

UpdatedNov 21, 2022

Conditions

Where5

Altasciences Clinical Los Angeles, Inc
Cypress, California, United States
Clinical Pharmacology of Miami
Miami, Florida, United States
Qps-Mra, Llc
Miami, Florida, United States

Clareo Health | A Study of LY3819469 in Healthy Participants